Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and Fibrosarcoma

sorafenib has been researched along with Fibrosarcoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Maeda, S; Momoi, Y; Yokota, S; Yonezawa, T1
Akatov, V; Bezborodova, O; Chekanov, A; Dolgikh, N; Evstratova, Y; Fadeev, R; Fadeeva, I; Kobyakova, M; Nemtsova, E; Senotov, A; Solovieva, M; Yakubovskaya, R1
Bouzin, C; Calderon, PB; Charette, N; Danhier, P; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Karroum, O; Kengen, J; Magat, J; Mignion, L; Sonveaux, P; Starkel, P; Verrax, J1

Other Studies

3 other study(ies) available for sorafenib and Fibrosarcoma

ArticleYear
Sorafenib inhibits tumor cell growth and angiogenesis in canine transitional cell carcinoma.
    The Journal of veterinary medical science, 2022, May-17, Volume: 84, Issue:5

    Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line, Tumor; Dog Diseases; Dogs; Fibrosarcoma; Mice; Mice, Nude; Neovascularization, Pathologic; Niacinamide; Rodent Diseases; Sorafenib; Tumor Microenvironment; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2022
Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD.
    International journal of molecular sciences, 2019, Jan-27, Volume: 20, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Fibrosarcoma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Recombinant Proteins; Sorafenib; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays

2019
Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: a rationale for combination with radiation therapy.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012, Volume: 105, Issue:1

    Topics: Angiogenesis Inducing Agents; Animals; Apoptosis; Benzamides; Blotting, Western; Diphenylamine; Electron Spin Resonance Spectroscopy; Fibrosarcoma; Glutathione; Liver Neoplasms, Experimental; Mice; Neoplasms, Experimental; Niacinamide; Oxygen Consumption; Phenylurea Compounds; Protein Kinase Inhibitors; Radiation Tolerance; Sorafenib

2012